secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2025-12-19T23:59:59+00:00
Accession:  0001213900-25-123912
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CERO stockholders approve reverse stock split (1:40–1:150) and 32M share increase to equity plan
--------------------------------------------------------------------------------

- Reverse stock split ratio set by board at not less than 1:40 or more than 1:150; approved with 8,012,563 for, 2,287,082 against.
- Issuance of common shares upon conversion of Series E preferred (Oct 2025 PIPE) approved; 3,304,540 for, 1,422,195 against.
- Equity incentive plan share reserve increased by 32,000,000 shares to 32,123,494 total; approved with 2,568,408 for.
- Quorum was 10,988,347 shares (52.82% of 20,802,671 outstanding) at the Dec 19, 2025 special meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025123912/0001213900-25-123912-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025123912/ea0270420-8k_cero.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-123912

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer